Literature DB >> 6695723

Hemodynamic effects of continuous abdominal binding during cardiac arrest and resuscitation.

J T Niemann, J P Rosborough, S Ung, J M Criley.   

Abstract

Abdominal binding improves arterial pressure and flow during cardiopulmonary resuscitation (CPR). This study was undertaken to assess the mechanisms of improved hemodynamics during cardiac arrest and CPR with continuous abdominal binding in a canine model (n = 8). Carotid and inferior vena caval (IVC) flow probes and cineangiography were used to observe magnitude and direction of blood flow. CPR with binding significantly increased (p less than 0.001) systolic aortic (Ao) (49 +/- 11 vs 34 +/- 12 mm Hg), right atrial (RA) (49 +/- 11 vs 31 +/- 10 mm Hg) and IVC pressure (50 +/- 7 versus 31 +/- 11 mm Hg) and common carotid flow (1.1 +/- 0.4 vs 0.7 +/- 0.4 ml/min/kg, p less than 0.05) compared with CPR without binding. Aortic, RA and IVC diastolic pressures increased similarly. Binding decreased the diastolic Ao-IVC pressure difference by 8 +/- 12 mm Hg and decreased net IVC flow (0.5 +/- 1.4 vs 1.4 +/- 1.2 ml/min/kg, p less than 0.05). Binding also decreased coronary perfusion pressure (Ao-RA) in 5 of 8 dogs. Cineangiograms showed tricuspid incompetence and reflux from the right atrium to the inferior vena cava during chest compression and IVC-to-right heart inflow during relaxation, which was confirmed by the flowmeter data. Abdominal binding during CPR decreased the size of the perfused vascular bed by inhibiting subdiaphragmatic flow and increased intrathoracic pressure for a given chest compression force, leading to preferential cephalad flow. However, coronary perfusion pressure was often adversely affected. Further studies should be undertaken before the widespread clinical application of continuous abdominal binding during CPR.

Entities:  

Mesh:

Year:  1984        PMID: 6695723     DOI: 10.1016/0002-9149(84)90438-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Mechanics of the circulation during cardiopulmonary resuscitation. Pathophysiology and techniques (Part II).

Authors:  J Peters; P Ihle
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Controlled pauses at the initiation of sodium nitroprusside-enhanced cardiopulmonary resuscitation facilitate neurological and cardiac recovery after 15 mins of untreated ventricular fibrillation.

Authors:  Demetris Yannopoulos; Nicolas Segal; Scott McKnite; Tom P Aufderheide; Keith G Lurie
Journal:  Crit Care Med       Date:  2012-05       Impact factor: 7.598

Review 3.  The physiology of cerebral blood flow during cardiopulmonary resuscitation.

Authors:  I D Berkowitz; M C Rogers
Journal:  Can J Anaesth       Date:  1988-05       Impact factor: 5.063

4.  Sodium nitroprusside enhanced cardiopulmonary resuscitation prevents post-resuscitation left ventricular dysfunction and improves 24-hour survival and neurological function in a porcine model of prolonged untreated ventricular fibrillation.

Authors:  Jason Schultz; Nicolas Segal; James Kolbeck; Emily Caldwell; Marit Thorsgard; Scott McKnite; Tom P Aufderheide; Keith G Lurie; Demetris Yannopoulos
Journal:  Resuscitation       Date:  2011-12       Impact factor: 5.262

5.  Sodium nitroprusside enhanced cardiopulmonary resuscitation (SNPeCPR) improves vital organ perfusion pressures and carotid blood flow in a porcine model of cardiac arrest.

Authors:  Jason Schultz; Nicolas Segal; James Kolbeck; Scott McKnite; Emily Caldwell; Demetris Yannopoulos
Journal:  Resuscitation       Date:  2011-08-22       Impact factor: 5.262

6.  A computerized prospective audit of cardiopulmonary resuscitation in the accident and emergency department.

Authors:  J Wardrope; A C Crosby; D G Ferguson; D L Edbrooke
Journal:  Arch Emerg Med       Date:  1986-09

7.  Acid base changes in arterial and central venous blood during cardiopulmonary resuscitation.

Authors:  D J Steedman; C E Robertson
Journal:  Arch Emerg Med       Date:  1992-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.